[1]陈晶,王萌,侯志涛.基于网络药理学的延胡索干预心力衰竭作用机制研究[J].中国中医药信息杂志,2020,27(3):71-77.[doi:10.3969/j.issn.1005-5304.201903319]
 CHEN Jing,WANG Meng,HOU Zhitao.Study on Mechanism of Intervention of Corydalis Rhizoma in Heart Failure Based on Network Pharmacology[J].zhongguo zhongyiyao xinxi zazhi,2020,27(3):71-77.[doi:10.3969/j.issn.1005-5304.201903319]
点击复制

基于网络药理学的延胡索干预心力衰竭作用机制研究

参考文献/References:

[1] PSOTKA M A, AMMON S E, FIUZAT M, et al. Heart failure site-based research in the United States:Results of the Heart Failure Society of America Research Network Survey[J]. JACC Heart Fail,2019,7(5)431-438.

[2] EDMONSTON D L, WU J, MATSOUAKA R A, et al. Association of post-discharge specialty outpatient visits with readmissions and mortality in high-risk heart failure patients[J]. Am Heart J, 2019,212:101-112.

[3] HARRINGTON C C. Evidence-based practice guideline:Assessing heart failure in long-term care facilities[J]. J Gerontol Nurs, 2019,45(7):18-24.

[4] SILVERMAN D N, SHAH S J. Treatment of heart failure with preserved ejection fraction (HFpEF):the phenotype-guided approach[J]. Curr Treat Options Cardiovasc Med,2019,21(4):20.

[5] WU L, LING H, LI L, et al. Beneficial effects of the extract from Corydalis yanhusuo in rats with heart failure following myocardial infarction[J]. J Pharm Pharmacol,2007,59(5):695-701.

[6] 汝锦龙.中药系统药理学数据库和分析平台的构建和应用[D].杨凌:西北农林科技大学,2015.

[7] CHEN L, CAO Y, ZHANG H, et al. Network pharmacology-based strategy for predicting active ingredients and potential targets of Yangxinshi tablet for treating heart failure[J]. J Ethnopharmacol, 2018,219:359-368.

[8] 王鹏军,苗阳,王健,等.慢性心力衰竭中医辨证客观化研究现状[J].中国中西医结合杂志,2013,33(6):854-857.

[9] 金鑫瑶,张俊华,张立双,等.张伯礼分期诊治慢性心力衰竭经验[J].中医杂志,2018,59(19):1633-1636.

[10] 郭丽君,马晓昌,王晓婧.马晓昌治疗心力衰竭经验[J].中华中医药杂志,2018,33(12):5438-5440.

[11] 姜楠,宁美,常诚,等.翁维良基于“解郁”治疗心血管疾病经验[J].中医杂志,2019,60(5):370-372.

[12] WANG L, ZHANG Y, WANG Z, et al. The antinociceptive properties of the Corydalis yanhusuo extract[J]. PLoS One,2016,11(9):e0162875.

[13] 李晶晶,张静怡,贺爱琴,等.延胡索炮制方法和功能主治历史沿革[J].中国中医药信息杂志,2014,21(4):134-136.

[14] 朱莉,王泰一,崔英,等.心律调节基因与抗心律失常中药靶标研究进展[J].中草药,2016,47(1):165-174.

[15] 申程,徐磊,杨志寅,等.SCN5A基因A1180V突变致扩张型心肌病(DCM)伴房室传导阻滞(AVB)的家系随访分析[J].复旦学报:医学版,2014, 41(2):174-178.

[16] 董丽君,周贤惠,李耀东,等.多脏器功能衰竭犬室性心律失常与KCNE1关系的研究[J].临床心血管病杂志,2017,33(6):580-583.

[17] KOSUMI K, HAMADA T, ZHANG S, et al. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer:Results from two prospective cohorts and CALGB 89803 (Alliance) trial[J]. Eur J Cancer,2019,111:82-93.

[18] 袁榴翼,李小锦,尹清晟,等.中药干预肠道菌群改善肠黏膜屏障功能的研究进展[J].中草药,2018,49(8):1932-1938.

[19] 刘秋雨,连增林.中药干预乳腺癌血管生成双途径研究进展[J].中国中医药信息杂志,2017,24(2):120-126.

[20] ZHANG L, GUO Z, WANG Y, et al. The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats[J]. Drug Dev Res,2019,80(3):294-309.

[21] NEVIERE R, YU Y, WANG L, et al. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions[J]. Glycoconj J,2016,33(4):607-617.

[22] ZHOU Y, OUYANG N, LIU L, et al. An EGLN1 mutation may regulate hypoxic response in cyanotic congenital heart disease through the PHD2/HIF-1A pathway[J]. Genes Dis,2019,6(1):35-42.

[23] DU Y, GE Y, XU Z, et al. Hypoxia-inducible factor 1 alpha (HIF-1alpha)/vascular endothelial growth factor (VEGF) pathway participates in angiogenesis of myocardial infarction in muscone- treated mice:preliminary study[J]. Med Sci Monit,2018,24:8870-8877.

[24] 张记收,王梦龙,刘剑芳,等.白细胞介素33及其受体在心血管疾病中的作用[J].中华老年心脑血管病杂志,2019,21(7):771-773.

相似文献/References:

[1]曹柳,窦志英,王萍,等.不同炮制方法对延胡索中有效成分含量的影响[J].中国中医药信息杂志,2009,16(6):42.
 CAO Liu,DOU Zhi-ying,WANG Ping,et al.Effect of Different Processes on the Contents of Active Ingredients in Corydalis[J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):42.
[2]赵益业,黄春林,林晓忠.心力衰竭的中西医结合治疗探析[J].中国中医药信息杂志,2007,14(2):81.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):81.
[3]周海峰,赵林颖,鲁宪凯,等.中西医结合治疗慢性收缩性心力衰竭临床观察[J].中国中医药信息杂志,2009,16(10):63.
 [J].zhongguo zhongyiyao xinxi zazhi,2009,16(3):63.
[4]张莉,付敏,韩建伟,等.复方元胡止痛贴中延胡索、白芷乙醇回流提取工艺研究[J].中国中医药信息杂志,2008,15(1):57.
 ZHANG Li,FU Min,HAN Jian-wei,et al.Optimization of Alcohol Refluxing Extraction Technique of Rhizoma Corydalis and Radix Angelicae Dahuricae in Compound Yuanhu Zhitong Patch[J].zhongguo zhongyiyao xinxi zazhi,2008,15(3):57.
[5]张宇.新生脉散片治疗射血分数保留的心力衰竭临床观察[J].中国中医药信息杂志,2011,18(5):75.[doi:10.3969/j.issn.1005-5304.2011.05.033]
 [J].zhongguo zhongyiyao xinxi zazhi,2011,18(3):75.[doi:10.3969/j.issn.1005-5304.2011.05.033]
[6]杨志旭,李洁,尚晓泓,等.心喘胶囊对犬实验性心力衰竭时神经内分泌过度激活的调节作用研究[J].中国中医药信息杂志,2007,14(12):25.
 YANG Zhi-xu,LI Jie,SHANG Xiao-hong,et al.Study on the Regulatory Effect of Xinchuan Capsules on the Excessive Aactivation of Neuroendocrine of Dogs with Experimental Heart Failure[J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):25.
[7]周贻,丁远英,谢雄伟.益气温阳利水法治疗老年慢性充血性心力衰竭[J].中国中医药信息杂志,2007,14(12):70.
 [J].zhongguo zhongyiyao xinxi zazhi,2007,14(3):70.
[8]黄山,陈峰,郭立玮.延胡索提取工艺的优选[J].中国中医药信息杂志,2006,13(1):47.
 HUANG Shan,CHEN Feng,GUO Li-wei.Optimum Selection of the Extracting Procedure of Rhizoma Corydalis[J].zhongguo zhongyiyao xinxi zazhi,2006,13(3):47.
[9]胡鸣旭,刘莉.黄芪甲苷对心力衰竭大鼠心肌细胞凋亡的影响[J].中国中医药信息杂志,2014,21(1):40.[doi:10.3969/j.issn.1005-5304.2014.01.013]
 HU Ming-xu,LIU Li.Effect of Astragaloside on Cardiomyocyte Apoptosis of Heart Failure Rats[J].zhongguo zhongyiyao xinxi zazhi,2014,21(3):40.[doi:10.3969/j.issn.1005-5304.2014.01.013]
[10]戴梅,温庆祥,何俊仁,等.心衰合剂对心肌梗死后心力衰竭大鼠的影响[J].中国中医药信息杂志,2006,13(12):28.
 DAI Mei,WEN Qing-xiang,HE Jun-ren,et al.Effects of Xinshuaiheji on Rats with Heart Failure after Acute Myocardial Infarction[J].zhongguo zhongyiyao xinxi zazhi,2006,13(3):28.

备注/Memo

基金项目:黑龙江省自然科学基金(H201485)(收稿日期:2019-03-25)

更新日期/Last Update:

2020-02-23